Review VEGFR-2 as a druggable target: recent advances (2025) in the development of five-membered heterocyclic anticancer agents. Mohamed M. Khalifa Ibtehal Naseer Salman Reyadh Jassem Sep 2026 · Future Medicinal Chemistry · pp. 1-20 · 0 citations Medicine DOI PubMed Semantic Scholar Save View source Cite Copy APA Copied ✓ Copy MLA Copied ✓ Copy BibTeX Copied ✓ Share